Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Kidney Specimen

Sponsor
Seoul National University Bundang Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05135520
Collaborator
(none)
106
2
24

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the outcomes of transvaginal natural orifice specimen extraction (NOSE) in patients who are planning multiport laparoscopic surgery for resection of kidney.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transvaginal natural orifice specimen extraction (NOSE)
  • Procedure: Transabdominal specimen extraction
N/A

Detailed Description

Study design:

This is a prospective, randomized, single center trial. This clinical trial was approved by the Institutional Review Boards.

Study process:

All patients gave informed written consent after being informed of the details of the study. Subjects were randomized into either the experimental group (specimen removal through posterior vagina fornix incision) or control groups (specimen removal through extended abdominal incision). All participants underwent demographic and history taking, laboratory tests, a gynecologic examination to determine whether specimen removal through vagina is possible.

To evaluate cosmesis, patient satisfaction and quality of life VAS (Visual Analogue Scale), SF-12 (Short Form-12) health survey, BIQ (Body Image Questionnaire) and POSAS (the Patient and Observer Scar Assessment Scale) will be sent to the patients 6 months after the surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
106 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Transvaginal specimen extraction vs Transabdominal specimen extractionTransvaginal specimen extraction vs Transabdominal specimen extraction
Masking:
Double (Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
A Prospective Randomized Controlled Study of Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Kidney Specimen (STTELS)
Anticipated Study Start Date :
Nov 29, 2021
Anticipated Primary Completion Date :
Nov 29, 2022
Anticipated Study Completion Date :
Nov 29, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transabdominal specimen extraction

The outcomes of transabdominal specimen extraction in a classic way in patients who underwent multiport laparoscopic surgery for resection of kidney

Procedure: Transabdominal specimen extraction
Under general anesthesia, patients who are planned to perform multiport laparoscopic surgery for resection of solid organs including kidney or bladder will undergo transabdominal specimen extraction with incision elongation

Experimental: Transvaginal natural orifice specimen extraction (NOSE)

The outcomes of transvaginal natural orifice specimen extraction (NOSE) in patients who underwent multiport laparoscopic surgery for resection of kidney

Procedure: Transvaginal natural orifice specimen extraction (NOSE)
Under general anesthesia, patients who are planned to perform multiport laparoscopic surgery for resection of solid organs including kidney or bladder will undergo Transvaginal NOSE

Outcome Measures

Primary Outcome Measures

  1. Patient and Observer Scar Assessment Scale (POSAS) [post-op 1 week]

    Cosmetic outcomes of scar assessed by Patient and Observer Scar Assessment Scale (POSAS) 1 week and 8 weeks after surgery. The POSAS is the international validated scar assessment questionnaire that measures quality of the scar from the perspective of both patient and observer. observer scar assessment scale (OSAS): good (1) - bad (10) - vascularization/ pigmentation/ thickness/ relief/ pliability patient scar assessment scale (PSAS): No (1) - Yes (10) Is the scar painful? Is the scar itching? Is the scar color different from the color of your normal skin? Is the stiffness of the scar different from the color of your normal skin? Is the thickness of the scar different from the color of your normal skin? Is the scar more irregular than your normal skin?

  2. Patient and Observer Scar Assessment Scale (POSAS) [post-op 8 weeks]

    Cosmetic outcomes of scar assessed by Patient and Observer Scar Assessment Scale (POSAS) 1 week and 8 weeks after surgery. The POSAS is the international validated scar assessment questionnaire that measures quality of the scar from the perspective of both patient and observer. observer scar assessment scale (OSAS): good (1) - bad (10) - vascularization/ pigmentation/ thickness/ relief/ pliability patient scar assessment scale (PSAS): No (1) - Yes (10) Is the scar painful? Is the scar itching? Is the scar color different from the color of your normal skin? Is the stiffness of the scar different from the color of your normal skin? Is the thickness of the scar different from the color of your normal skin? Is the scar more irregular than your normal skin?

Secondary Outcome Measures

  1. Vaginal wound assessment [post-op 1 week]

    assessment scale: No (0) - Yes (3) Vaginal bleeding Vaginal discharge Vaginal wound pain

  2. Vaginal wound assessment [post-op 8 weeks]

    assessment scale: No (0) - Yes (3) Vaginal bleeding Vaginal discharge Vaginal wound pain

  3. Post-op pain assessment [post-op 2hrs]

    Pain assessment with Visual analogue scale: No pain (0) - Worst pain (10)

  4. Post-op pain assessment [post-op 6hrs]

    Pain assessment with Visual analogue scale: No pain (0) - Worst pain (10)

  5. Post-op pain assessment [post-op 24hrs]

    Pain assessment with Visual analogue scale: No pain (0) - Worst pain (10)

  6. Post-op pain assessment [post-op 48hrs]

    Pain assessment with Visual analogue scale: No pain (0) - Worst pain (10)

  7. Female Sexual Function Index (FSFI) questionnaire [post-op 5 months]

    Assessment Domain: Desire/ Arousal/ Lubrication/ Orgasm/ Satisfaction/ Pain Full scale score range: min 2.0 - max 36

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients who are accessible with vaginal approach

  • Patients scheduled for laparoscopic resection of kidney for benign or malignant diseases

  • Patients with normal cervical cancer screening tests within the last 3 years except inflammatory findings

Exclusion Criteria:
  • Patients without sexual intercourse

  • Patients who are considered unable to remove specimen through vagina due to narrow introitus in gynecological examination

  • Patients who are expected to have severe adhesion due to deep infiltrative endometriosis or previous pelvic surgery history

  • Patients with abnormal cervical cancer screening tests

  • Patients scheduled to perform concomitant hysterectomy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Seoul National University Bundang Hospital

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT05135520
Other Study ID Numbers:
  • SNUBH B-2105-687-003
First Posted:
Nov 26, 2021
Last Update Posted:
Nov 26, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Seoul National University Bundang Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 26, 2021